Share
University Hospital Bristol has presented groundbreaking results at the British Radiation Safety Society (BRSS) conference, showcasing the use of TrueInvivo’s® DOSEmapper™ technology in gamma knife radiosurgery. The innovative micro silica bead TLD system provided precise dose measurements, ensuring accurate delivery and improved patient safety in stereotactic radiosurgery.
This marks a significant advancement in dosimetry, highlighting the potential of DOSEmapper™ to enhance radiation safety and accuracy in complex treatments.
Related Posts
TRUEinvivo wins Business Innovation of the Year Award for DOSEmapper™ technology, revolutionizing radiotherapy safety.
Graduate secures vital government backing for innovative cancer treatment, targeting global markets with Sirius Programme.
Dr. Shakar Jafari wins prestigious 'Women in Innovation' award for groundbreaking contributions to healthcare.
Mount Vernon Cancer Centre pioneers first internal invivo dosimetry with TRUEnvivo® DOSEmapper™, revolutionising radiotherapy precision, patient safety, and treatment accuracy.
